Tubigon, Jerry P.
HRN: 22-44-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/17/2024
12/24/2024
IV
300mg
Every 12hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes